Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma

We have recently reported tumor suppressive role of DAB2IP in RCC development. In this study, We identified one CpG methylation biomarker (DAB2IP CpG1) located UTSS of DAB2IP that was associated with poor overall survival in a cohort of 318 ccRCC patients from the Cancer Genome Atlas (TCGA). We furt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Wang, Zong-Ren, Wei, Jin-Huan, Zhou, Jian-Cheng, Haddad, Ahmed, Zhao, Liang-Yun, Kapur, Payal, Wu, Kai-Jie, Wang, Bin, Yu, Yan-Hong, Liao, Bing, He, Da-Lin, Chen, Wei, Margulis, Vitaly, Hsieh, Jer-Tsong, Luo, Jun-Hang
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2016
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5058774/
https://ncbi.nlm.nih.gov/pubmed/27129174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8971
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge